Are you Dr. Beaver?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 80 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
The Johns Hopkins Hospital
600 North Wolfe Street
Baltimore, MD 21287Phone+1 410-955-5000- Is this information wrong?
Summary
- Dr. Julia Beaver, MD is an oncologist in Baltimore, Maryland. She is currently licensed to practice medicine in Maryland and District of Columbia.
Education & Training
- Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2010 - 2013
- Johns Hopkins UniversityResidency, Internal Medicine, 2007 - 2010
- Perelman School of Medicine at the University of PennsylvaniaClass of 2007
Certifications & Licensure
- MD State Medical License 2010 - 2024
- DC State Medical License 2013 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 1 citationsThe Development of the Oncology Center of Excellence Patient-Friendly Language Glossary of Oncology Clinical Trial Terms.Danielle Krol, Janice Kim, Jennifer Gao, Laleh Amiri-Kordestani, Julia A Beaver, Paul Kluetz> ;The Oncologist. 2023 May 8
- Differential Protein Citrullination in Human ER- and ER+ Tumor and Adjacent Healthy Breast Tissue.Joseph Tillotson, Baikuntha Aryal, Lo Lai, Julia A Beaver, V Ashutosh Rao> ;Biochemistry. 2023 Feb 21
- 18 citationsUS Food and Drug Administration Approval Summary: Fam-Trastuzumab Deruxtecan-nxki for Human Epidermal Growth Factor Receptor 2-Low Unresectable or Metastatic Breast Ca...Preeti Narayan, Asma Dilawari, Christy Osgood, Zhou Feng, Erik Bloomquist, William F Pierce, Samina Jafri, Shyam Kalavar, Marina Kondratovich, Prakash Jha, Shenghui Ta...> ;Journal of Clinical Oncology. 2023 Apr 10
- Join now to see all
Press Mentions
- Targeted Oncology - FDA Cracks down on Dangling Accelerated Approvals in 2021, Pathway Is ScrutinizedDecember 20th, 2021
- FDA Posts New Websites on Accelerated Approvals for Cancer DrugsOctober 29th, 2021
- The FDA’s Accelerated Approval Process: When Drugs Are Cleared for Sale Based on Limited EvidenceOctober 18th, 2021
- Join now to see all